Please login to the form below

Not currently logged in
Email:
Password:

Alkermes cuts jobs in Ireland as Novartis invests

130 jobs to go at manufacturing facility in Athlone as Novartis creates 100 roles in Dublin

Alkermes cuts jobs in Ireland as Novartis investsAlkermes has announced plans to slash up to 130 staff at its manufacturing facility in Athlone, Ireland, in the latest piece of discouraging news for the country's pharma sector.

The news was offset however by Novartis' announcement that it plans to establish a business services centre at its Beech Hill site in Dublin, creating around 100 jobs.

Alkermes said its decision was a result of falling sales of some of the products manufactured at the plant. These products have lost patent protection and are coming to the end of their commercial life.

The layoffs will happen over the next two years and take place through natural attrition and a combination of voluntary and compulsory redundancies. They will provide annual savings of $15m-$20m by 2016.

Alkermes currently employs around 440 people at Athlone and at its headquarters in Dublin, many of whom came under its banner after the $960m takeover of Elan's drug technology unit in 2011.

A report in the Irish Times notes that the decision to cut staff at Athlone was at odds with comments made by Alkermes chief executive Richard Pops when the Elan deal concluded, in which he suggested that additional recruitment at the site was on the cards.

The news comes on the back of other cutbacks at Irish facilities in recent months, notably Merck & Co's decision to close its Rathdrum plant with the loss of 280 jobs, the shutting down of a GlaxoSmithKline financial services centre in Cork and the loss of 200 jobs at Abbott's medical devices production unit in Clonmel.

On the plus side, there have been gains for the Irish drug sector, including Sanofi's decision to spend €44m upgrading its Waterford facility and GSK's €76m investment programme in Dublin and Galway that could create up to 500 jobs. GSK also elected not to close a plant in Sligo operated by its Stiefel subsidiary.

Novartis unit
Meanwhile, Novartis said its new business services centre would "consolidate digital marketing, salesforce training and medical communications services" for the company. The unit will be housed temporarily at the Beech Hill campus while another permanent location is sought.

The pharma giant already has a significant presence in Ireland, employing more than 1,200 people in its two Cork-based manufacturing plants and its commercial operations in Dublin.

10th April 2013

From: PME

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics